❗Senators grilled Heidi Overton, MD, on vaccines, food safety, mifepristone and more during her hearing to become #FDAcommissioner. #MedTwitter#HealthNews
🔗Read more with insight from @ArthurCaplan: https://t.co/x4GSlLmKeO
🩺 Recent study links 5 major adverse pregnancy outcomes to elevated risk for peripheral artery disease up to 4 decades later.
Results highlight need to identify high-risk women early to protect long-term health.
#CardioObstetrics@UTHealthHouston
https://t.co/4TsiW3G3jS
💉 Among adults with type 2 #diabetes and #obesity who received enicepatide for 48 weeks:
📌 90% had an HbA1c of 6.5% or less
📌 62% had an HbA1c of less than 5.7%
@Roche@GoHealio
https://t.co/CscQm2qype
From vaccine questions to CME opportunities, Healio AI can help support your clinical learning and workflow. Try a sample prompt and explore what’s possible 👉 https://t.co/4LRj2XbGC2
#HealioAI#ClinicalAI
🧒 Incidence of both type 1 and type 2 #diabetes increased from 2002 to 2023, with type 2 diabetes rates particularly rising from 2014 to 2023, according to data that will be presented at #EASD2026.
@CUAnschutz@EASDnews@IDinChildren
https://t.co/sZcCF5S923
Individuals with #IBD reported improvements in quality of life and reduced reliance on opioids with daily #marijuana use.
🗨️ These results may demonstrate a path to “avoid potential opioid dependence and addiction,” said Dr. Naueen Chaudhry @UFMedicine. https://t.co/VwonvvUlMo
💬"Asking only whether someone smokes #cigarettes🚬 is no longer enough,” Charmaine Helk-Lim, PhD, of Ludwig Boltzmann Institute for Lung Health, told Healio. #vaping
https://t.co/lpEMfE8XdV
💰Tax planning isn’t just about lowering this year’s tax bill. It can affect how much wealth doctors build over their career.
A new white paper quantifies the potential value of coordinated tax planning. Learn more in this Residency to Retirement column:
https://t.co/gCIcNJKids
📢 “The key result is straightforward: Sexual intercourse does not increase the risk of clinically significant hypoglycemia.”
Dr. Dominika Orłowska discusses her research that will be presented at #EASD2026 next week.
@EASDnews@GoHealio
https://t.co/70E6Dmnzhx
🏃Nutrition and lifestyle strategies can benefit the long-term success of #GLP1 use, according to the Kathleen A. Fincher, MS, RD, LD, CDCES and Casey Fiocchi, RD, LD, CDCES of @theprismahealth.
Read about their insights 👇
https://t.co/wv5H4uRrBh
🚨 The @US_FDA has approved a second once-weekly basal insulin for adults with type 2 #diabetes.
Read more about Onswik and the QWINT trial program that led to its approval ⬇️
@EliLillyandCo@GoHealio
https://t.co/4B2mtUg71s
💊 Oral menopausal hormone therapy, particularly when taken at a dose of more than 1 mg per day, may increase risk for multiple thrombotic events for women.
Learn more about this new @bmj_latest study ⬇️
@Stenodiabetes@CardiologyToday@healiowomen
https://t.co/tqfGO286wA
📢 “This trial shows that vosoritide is effective at improving growth in children with hypochondroplasia. It will hopefully lead to approval of the first precision medication for this condition.”
Hear more from Dr. Andrew Dauber of @ChildrensNatl 👇
https://t.co/K5s2kwEFNM
🚨More from @TheLancet and #ESCCongress🚨
Early statin initiation after a diagnosis of type 2 diabetes was associated with lower absolute and relative risk for all-cause dementia vs. no statin initiation
@GoHealio#ESC365@escardio@escardionews
https://t.co/NkDDc3QVmY
❗ICYMI: Check out this #HealioExclusive that dives deep into the Lindsay Clancy trial and evaluates what the case reveals about gaps in women's healthcare.
🔗Read more: https://t.co/znEZrOGBVO
❗BREAKING: CMS said it is taking action to combat alleged fraud in the Affordable Care Act program, including canceling covering for 760,000.
🔗Read more, with insight from @ArthurCaplan: https://t.co/kWmCQEICGM
Is your current AI smart enough to keep up with you?
Healio AI learns your preferences and builds on past conversations to optimize your daily workflow.
Try it today: Compare recently updated clinical guidelines from major organizations. https://t.co/mFRGfPwVm5
🚨 A once-weekly GLP-1/GIP dual agonist reduced HbA1c by up to 2.65 percentage points at 48 weeks for adults with type 2 #diabetes, according to topline results released by @Roche.
Learn more about enicepatide ⬇️
@GoHealio
https://t.co/iP1aUKIdK7
💡 Adults with type 1 #diabetes do not experience increased risk for hypoglycemia in the 2 hours after sexual activity.
Read more about this small study that will be presented at #EASD2026 ⬇️
@EASDnews@GoHealio
https://t.co/k2LHgjv9W5